121 related articles for article (PubMed ID: 8281939)
1. A plasma membrane 'vacuum cleaner' for daunorubicin in non-P-glycoprotein multidrug-resistant SW-1573 human non-small cell lung carcinoma cells. A study using fluorescence resonance energy transfer.
Mülder HS; van Grondelle R; Westerhoff HV; Lankelma J
Eur J Biochem; 1993 Dec; 218(3):871-82. PubMed ID: 8281939
[TBL] [Abstract][Full Text] [Related]
2. Daunorubicin efflux against a concentration gradient in non-P-glycoprotein multidrug-resistant lung-cancer cells.
Mülder HS; Lankelma J; Dekker H; Broxterman HJ; Pinedo HM
Int J Cancer; 1994 Oct; 59(2):275-81. PubMed ID: 7927929
[TBL] [Abstract][Full Text] [Related]
3. Energy-dependent processes involved in reduced drug accumulation in multidrug-resistant human lung cancer cell lines without P-glycoprotein expression.
Versantvoort CH; Broxterman HJ; Pinedo HM; de Vries EG; Feller N; Kuiper CM; Lankelma J
Cancer Res; 1992 Jan; 52(1):17-23. PubMed ID: 1309222
[TBL] [Abstract][Full Text] [Related]
4. Probing daunorubicin accumulation defects in non-P-glycoprotein expressing multidrug-resistant cell lines using digitonin.
Versantvoort CH; Broxterman HJ; Feller N; Dekker H; Kuiper CM; Lankelma J
Int J Cancer; 1992 Apr; 50(6):906-11. PubMed ID: 1348241
[TBL] [Abstract][Full Text] [Related]
5. The multidrug-resistance-reverser verapamil interferes with cellular P-glycoprotein-mediated pumping of daunorubicin as a non-competing substrate.
Spoelstra EC; Westerhoff HV; Pinedo HM; Dekker H; Lankelma J
Eur J Biochem; 1994 Apr; 221(1):363-73. PubMed ID: 7909520
[TBL] [Abstract][Full Text] [Related]
6. Genistein modulates the decreased drug accumulation in non-P-glycoprotein mediated multidrug resistant tumour cells.
Versantvoort CH; Schuurhuis GJ; Pinedo HM; Eekman CA; Kuiper CM; Lankelma J; Broxterman HJ
Br J Cancer; 1993 Nov; 68(5):939-46. PubMed ID: 8105867
[TBL] [Abstract][Full Text] [Related]
7. Cross-resistance to antifolates in multidrug resistant cell lines with P-glycoprotein or multidrug resistance protein expression.
van Triest B; Pinedo HM; Telleman F; van der Wilt CL; Jansen G; Peters GJ
Biochem Pharmacol; 1997 Jun; 53(12):1855-66. PubMed ID: 9256160
[TBL] [Abstract][Full Text] [Related]
8. P-glycoprotein does not reduce substrate concentration from the extracellular leaflet of the plasma membrane in living cells.
Chen Y; Pant AC; Simon SM
Cancer Res; 2001 Nov; 61(21):7763-9. PubMed ID: 11691790
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of daunorubicin transport by P-glycoprotein of intact cancer cells.
Spoelstra EC; Westerhoff HV; Dekker H; Lankelma J
Eur J Biochem; 1992 Jul; 207(2):567-79. PubMed ID: 1353020
[TBL] [Abstract][Full Text] [Related]
10. Multidrug resistance-modifying components in human plasma with potential clinical significance.
Mülder HS; Pinedo HM; Timmer AT; Rao BR; Lankelma J
J Exp Ther Oncol; 1996 Jan; 1(1):13-22. PubMed ID: 9414384
[TBL] [Abstract][Full Text] [Related]
11. Role of the plasma membrane leaflets in drug uptake and multidrug resistance.
Katzir H; Yeheskely-Hayon D; Regev R; Eytan GD
FEBS J; 2010 Mar; 277(5):1234-44. PubMed ID: 20121943
[TBL] [Abstract][Full Text] [Related]
12. Modulation of P-glycoprotein-mediated multidrug resistance by acceleration of passive drug permeation across the plasma membrane.
Regev R; Katzir H; Yeheskely-Hayon D; Eytan GD
FEBS J; 2007 Dec; 274(23):6204-14. PubMed ID: 17986257
[TBL] [Abstract][Full Text] [Related]
13. A model for computer simulation of P-glycoprotein and transmembrane delta pH-mediated anthracycline transport in multidrug-resistant tumor cells.
Demant EJ; Sehested M; Jensen PB
Biochim Biophys Acta; 1990 Nov; 1055(2):117-25. PubMed ID: 2242381
[TBL] [Abstract][Full Text] [Related]
14. Bidirectional transbilayer lipid movement in human platelets as vizualized by the fluorescent membrane probe 1-[4-(trimethylammonio)phenyl]-6-phenyl-1,3,5-hexatriene.
Bevers EM; Verhallen PF; Visser AJ; Comfurius P; Zwaal RF
Biochemistry; 1990 May; 29(21):5132-7. PubMed ID: 2378868
[TBL] [Abstract][Full Text] [Related]
15. Genetic transfer of non-P-glycoprotein-mediated multidrug resistance (MDR) in somatic cell fusion: dissection of a compound MDR phenotype.
Eijdems EW; Borst P; Jongsma AP; de Jong S; de Vries EG; van Groenigen M; Versantvoort CH; Nieuwint AW; Baas F
Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3498-502. PubMed ID: 1348862
[TBL] [Abstract][Full Text] [Related]
16. P-glycoprotein drug efflux pump involved in the mechanisms of intrinsic drug resistance in various colon cancer cell lines. Evidence for a saturation of active daunorubicin transport.
Spoelstra EC; Dekker H; Schuurhuis GJ; Broxterman HJ; Lankelma J
Biochem Pharmacol; 1991 Feb; 41(3):349-59. PubMed ID: 1671638
[TBL] [Abstract][Full Text] [Related]
17. Cooperative P-glycoprotein mediated daunorubicin transport into DNA-loaded plasma membrane vesicles.
Guiral M; Viratelle O; Westerhoff HV; Lankelma J
FEBS Lett; 1994 Jun; 346(2-3):141-5. PubMed ID: 7912204
[TBL] [Abstract][Full Text] [Related]
18. Cellular daunomycin fluorescence in multidrug resistant 2780AD cells and its relation to cellular drug localisation.
Lankelma J; Mülder HS; van Mourik F; Wong Fong Sang HW; Kraayenhof R; van Grondelle R
Biochim Biophys Acta; 1991 Jul; 1093(2-3):147-52. PubMed ID: 1863594
[TBL] [Abstract][Full Text] [Related]
19. Saturable P-glycoprotein kinetics assayed by fluorescence studies of drug efflux from suspended human KB8-5 cells.
Ghauharali RI; Westerhoff HV; Dekker H; Lankelma J
Biochim Biophys Acta; 1996 Jan; 1278(2):213-22. PubMed ID: 8593279
[TBL] [Abstract][Full Text] [Related]
20. Single cell analysis of daunomycin uptake and efflux in multidrug-resistant and -sensitive KB cells: effects of verapamil and other drugs.
Willingham MC; Cornwell MM; Cardarelli CO; Gottesman MM; Pastan I
Cancer Res; 1986 Nov; 46(11):5941-6. PubMed ID: 3756931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
